Editorial Commentary: Should “heterogeneous response” be considered as new category for assessing treatment response in patients with breast cancer?
More Info
expand_more
expand_more
Files
S00259-024-07042-9.pdf
(pdf | 0.88 Mb)
Unknown license
warning
File under embargo until 21-06-2025